stockrowelectroCore, Inc. (ECOR) vs Nyxoah SA (NYXH)
- electroCore, Inc. ECOR 8.13 −7.61%
- Nyxoah SA NYXH 0.85 +4.94%
electroCore, Inc. and Nyxoah SA are both Medical Devices companies. electroCore, Inc. and Nyxoah SA are of similar size ($82.6M and $79.3M). Nyxoah SA grew revenue faster over the last twelve months: 366.2% against 27.3%. electroCore, Inc. has the higher net margin (−33.5% vs −446.4%) and the lower return on invested capital (−193.1% vs −117.8%). Across the 17 metrics below, electroCore, Inc. leads on 10 and Nyxoah SA on 7.
Valuation
Profitability
| Metric | ECOR | NYXH | Medical Devices median |
|---|---|---|---|
| Gross margin | 87.67% | 60.16% | 57.76% |
| Operating margin | (33.15%) | (391.25%) | (15.07%) |
| Net margin | (33.46%) | (446.39%) | (14.45%) |
| Free cash flow margin | (28.70%) | (344.99%) | (3.88%) |
| Return on equity | 709.52% | (124.41%) | (10.35%) |
| Return on assets | (65.70%) | (68.23%) | (17.26%) |
| Return on invested capital | (193.07%) | (117.82%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack